Abstracts

Search by keyword or author name.

Showing 852 abstracts.

Linh Y. Ngo, F.N.P., Ram Yogev, M.D., Wayne M. Dankner, M.D., Walter T. Hughes, M.D., Jing Xu, M.S., Jashvant D. Unadkat, Ph.D. Pharmacokinetics of azithromycin (AZ) when administered alone and with atovaquone (AT). Presented at: 5th Conference on Retroviruses & Opportunistic Infections.

Conference

5th Conference on Retroviruses & Opportunistic Infections
Anh P. Ta, Mary E. Paul, Nathan J. Hanan, Yanling Huo, Suad Kapetanovic, George Siberry, Elizabeth Smith, Pim Brouwers, Edmund V. Capparelli, Brookie M. Best. Pharmacokinetics of citalopram and escitalopram in HIV-infected and uninfected adolescents. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; 2017 Dec 04.

Conference

American Society of Health-System Pharmacists Midyear Clinical Meeting

Study

P1080
Pharmacokinetics of Darunavir (DRV) 800 mg with Ritonavir 100 mg Once Daily in HIV-Infected Adolescents and Young Adults. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.

Conference

20th Conference on Retroviruses and Opportunistic Infections

Study

P1058A
J Momper, B Best, J Wang, A Stek, DE Shapiro, K George, E Barr, K Rungruengthanakit, E Smith, N Chakhtoura, EV Capparelli, M Mirochnick. Pharmacokinetics of darunavir boosted with cobicistat during pregnancy and postpartum. Presented at: IAS 2018.

Conference

IAS 2018

Study

P1026S
J Momper, Brookie Best, J Wang, Alice Stek, David Shapiro, Kathy George, Emily Barr, Kittipong Rungruengthanakit, E Smith, N Chakhtoura, E Capparelli, M Mirochnick, IMPAACT P1026s Protocol Team. PHARMACOKINETICS OF DARUNAVIR BOOSTED WITH COBICISTAT DURING PREGNANCY AND POSTPARTUM. Presented at: CROI 2018.

Conference

CROI 2018

Study

P1026S
Pharmacokinetics of Darunavir Once or Twice Daily During Pregnancy and Postpartum.

Study

P1026S
Pharmacokinetics of Increased Dose Atazanavir with and without Tenofovir During Pregnancy. Presented at: 12th International Workshop on Clinical Pharmacology of HIV Therapy.

Conference

12th International Workshop on Clinical Pharmacology of HIV Therapy

Study

P1026S
Alice Stek, Brookie Best, Edmund Caparrelli, JiaJia Wang, David Shapiro, Tim Cressey, Elizabeth Smith, Regis Kreitchman, Nahida Chakhtoura, Mark Mirochnick for the IMPAACT P1026s team. Pharmacokinetics of increased dose darunavir during late pregnancy and postpartum. Presented at: CROI 2016; 2016 Feb 23.

Conference

CROI 2016

Study

P1026S
John H. Rodman, Pharm.D., Ram Yogev, M.D., Elaine J. Abrams, M.D., Stephen Ira Pelton, M.D., Pearl Samson, M.S., Terence Fenton, Ed.D., Ellen Gould Chadwick, M.D. Pharmacokinetics of Indinavir (IDV) at Two Dose Levels of Ritonavir (RTV) for HIV-infected Children Failing Antiretroviral Therapy.

Study

P1013
Jennifer J. Kiser, Pharm.D., Sharon Appelbaum Nachman, M.D., Charles Debeaux Mitchell, M.D., George D. McSherry, M.D., Shabir A. Madhi, M.D., Avy Violari, M.D., Mark F. Cotton, MMED, Ph.D., MB ChB, Soyeon Kim, Ph.D., Heiner Seifart, Courtney V. Fletcher, Pharm.D. Pharmacokinetics of isoniazid in preventing tuberculosis disease and latent infection in African HIV-exposed uninfected and HIV-infected infants. Presented at: 47th Intersci Conf on Antimicrobial Agents & Chemotherapy.

Conference

47th Intersci Conf on Antimicrobial Agents & Chemotherapy

Study

P1041